KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Debt Ratio (2016 - 2024)

Biomarin Pharmaceutical's Debt Ratio history spans 14 years, with the latest figure at 0.07 for Q2 2024.

  • For the quarter ending Q2 2024, Debt Ratio changed N/A year-over-year to 0.07, compared with a TTM value of 0.07 through Jun 2024, changed N/A, and an annual FY2023 reading of 0.07, changed N/A over the prior year.
  • Debt Ratio for Q2 2024 was 0.07 at Biomarin Pharmaceutical, down from 0.07 in the prior quarter.
  • The five-year high for Debt Ratio was 0.08 in Q1 2020, with the low at 0.0 in Q3 2022.
  • Average Debt Ratio over 5 years is 0.04, with a median of 0.01 recorded in 2022.
  • Year-over-year, Debt Ratio surged 2989.55% in 2020 and then plummeted 93.15% in 2021.
  • Tracing BMRN's Debt Ratio over 5 years: stood at 0.06 in 2020, then crashed by 86.78% to 0.01 in 2021, then tumbled by 43.75% to 0.0 in 2022, then surged by 1497.65% to 0.07 in 2023, then dropped by 3.0% to 0.07 in 2024.
  • Per Business Quant, the three most recent readings for BMRN's Debt Ratio are 0.07 (Q2 2024), 0.07 (Q1 2024), and 0.07 (Q4 2023).